Peter Cervoni
-
- Renin-Angiotensin System Studies 11
- Cardiac electrophysiology and arrhythmias 9
- Physiology top 10%
- Nitric Oxide and Endothelin Effects 14
- Adipose Tissue and Metabolism 7
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 14
-
- Neurotransmitter Receptor Influence on Behavior 6
- Animal Science and Zoology top 10%
-
- Receptor Mechanisms and Signaling 18
-
- Inflammatory mediators and NSAID effects 12
- Co-authors
- S. M. KirpekarDavid L. CrandallF.M. LaiRobert F. FurchgottTheodore C. WestPeter S. ChanG. FalkY. T. Shen
- Journals
- Journal of Pharmacology and Experimental Therapeutics (19 papers)Life Sciences (6 papers)Experimental Biology and Medicine (5 papers)
- Partner nations
- United StatesChinaBelgium
In The Last Decade
Peter Cervoni
81 papers receiving 939 citations
Peers
Comparison fields: 5 of 95
- Cardiology and Cardiovascular Medicine 408
- Physiology 348
- Biochemistry 85
- Cellular and Molecular Neuroscience 178
- Animal Science and Zoology 78
Countries citing papers authored by Peter Cervoni
This map shows the geographic impact of Peter Cervoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Cervoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Cervoni more than expected).
Fields of papers citing papers by Peter Cervoni
This network shows the impact of papers produced by Peter Cervoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Cervoni. The network helps show where Peter Cervoni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Cervoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 5 | |
| 2 | 1993 | 38 | |
| 3 | 1992 | 29 | |
| 4 | 1991 | 3 | |
| 5 | 1990 | 1 | |
| 6 | 1989 | 5 | |
| 7 | 1989 | 14 | |
| 8 | 1989 | 25 | |
| 9 | 1988 | 5 | |
| 10 | 1988 | 16 | |
| 11 | 1988 | 1 | |
| 12 | 1987 | 2 | |
| 13 | CL 115,347 (DHV-PGE2 ME): a new orally and topically active prostaglandin antihypertensive agent. | 1983 | 7 |
| 14 | 1975 | 3 | |
| 15 | 1966 | 12 | |
| 16 | 1963 | 6 | |
| 17 | 1963 | 61 | |
| 18 | 1962 | 8 | |
| 19 | 1962 | 22 | |
| 20 | 1953 | 16 |
About Peter Cervoni
Peter Cervoni is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine, Physiology, Cellular and Molecular Neuroscience and Pharmacology, having authored 82 papers that have together received 1.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (18 papers), Nitric Oxide and Endothelin Effects (14 papers), Eicosanoids and Hypertension Pharmacology (14 papers), Inflammatory mediators and NSAID effects (12 papers), Renin-Angiotensin System Studies (11 papers), Cardiac electrophysiology and arrhythmias (9 papers), Adipose Tissue and Metabolism (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (408 citations), Physiology (348 citations), Biochemistry (85 citations), Cellular and Molecular Neuroscience (178 citations) and Animal Science and Zoology (78 citations). Peter Cervoni has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include S. M. Kirpekar, David L. Crandall, F.M. Lai, Robert F. Furchgott, Theodore C. West, Peter S. Chan, G. Falk, Y. T. Shen, S. F. Vatner and Brian Saunders. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Life Sciences, Experimental Biology and Medicine, British Journal of Pharmacology and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.